This Study Combines Data From 3 Other Studies Testing Empagliflozin in Patients With Diabetes or With Chronic Heart Failure. The Study Looks at the Numbers of Patients Who Had Lower Limb Amputations
Clinical trial NCT04937816 · COMPLETED
Trial details
- NCT number
- NCT04937816
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-06-01
- Primary completion
- 2021-07-13
- Enrollment
- 16746
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.